BioCentury
ARTICLE | Clinical News

GAP3KO vaccine: Ph I data

January 6, 2017 10:30 PM UTC

An open-label, U.S. Phase I trial in 10 healthy volunteers showed that GAP3KO administered via the bite of 150-200 GAP3KO-infected mosquitoes under controlled conditions prevented malaria infection in...